Cognition Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Pittsburgh PA United States (2007)

Organization Overview

First Clinical Trial
2007
NCT00529581
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Cognition Pharmaceuticals, LLC | Cognition Therapeutics | Cognition Therapeutics Inc. | Cognition Therapeutics, Inc. | Cognition Therapuetics